Trupanion Inc (NASDAQ:TRUP) has been assigned a consensus rating of “Buy” from the ten analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, six have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $40.40.
TRUP has been the topic of several research reports. Zacks Investment Research lowered Trupanion from a “hold” rating to a “sell” rating in a research report on Friday, August 2nd. BidaskClub lowered Trupanion from a “buy” rating to a “hold” rating in a research report on Friday, July 19th. TheStreet lowered Trupanion from a “c” rating to a “d+” rating in a research report on Tuesday, July 30th. ValuEngine raised Trupanion from a “buy” rating to a “strong-buy” rating in a research report on Thursday. Finally, Northland Securities reaffirmed a “buy” rating and issued a $40.00 target price on shares of Trupanion in a research report on Wednesday, July 31st.
Shares of Trupanion stock traded down $2.18 during trading hours on Tuesday, reaching $30.49. 285,406 shares of the company’s stock were exchanged, compared to its average volume of 191,801. Trupanion has a 52-week low of $22.38 and a 52-week high of $40.26. The company has a market capitalization of $1.14 billion, a price-to-earnings ratio of -1,016.33 and a beta of 1.31. The company’s fifty day moving average is $33.72. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.80 and a quick ratio of 1.80.
In other Trupanion news, Director Dan Levitan sold 15,000 shares of the firm’s stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $29.56, for a total value of $443,400.00. Following the transaction, the director now directly owns 73,487 shares of the company’s stock, valued at $2,172,275.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CRO Margaret Tooth sold 750 shares of the firm’s stock in a transaction dated Tuesday, June 18th. The shares were sold at an average price of $34.69, for a total value of $26,017.50. The disclosure for this sale can be found here. Insiders sold a total of 57,850 shares of company stock worth $1,827,683 over the last ninety days. Corporate insiders own 13.61% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in TRUP. Bank of New York Mellon Corp grew its stake in shares of Trupanion by 5.4% during the 4th quarter. Bank of New York Mellon Corp now owns 93,334 shares of the financial services provider’s stock valued at $2,376,000 after purchasing an additional 4,801 shares during the period. Citigroup Inc. grew its stake in shares of Trupanion by 12,818.2% during the 4th quarter. Citigroup Inc. now owns 2,842 shares of the financial services provider’s stock valued at $72,000 after acquiring an additional 2,820 shares during the period. Northern Trust Corp grew its stake in shares of Trupanion by 7.0% during the 4th quarter. Northern Trust Corp now owns 367,116 shares of the financial services provider’s stock valued at $9,347,000 after acquiring an additional 23,892 shares during the period. Great West Life Assurance Co. Can grew its stake in shares of Trupanion by 105.1% during the 4th quarter. Great West Life Assurance Co. Can now owns 3,691 shares of the financial services provider’s stock valued at $91,000 after acquiring an additional 1,891 shares during the period. Finally, Dimensional Fund Advisors LP bought a new position in shares of Trupanion during the 4th quarter valued at approximately $860,000. 97.60% of the stock is currently owned by institutional investors.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Further Reading: What Are Cryptocurrencies?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.